Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study
Crossref DOI link: https://doi.org/10.1007/s00198-016-3503-0
Published Online: 2016-02-15
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rizzoli, R.
Benhamou, C.-L.
Halse, J.
Miller, P. D.
Reid, I. R.
Rodríguez Portales, J. A.
DaSilva, C.
Kroon, R.
Verbruggen, N.
Leung, A. T.
Gurner, D.
Text and Data Mining valid from 2016-02-15